Kotak Upgrades Biocon to Add, Sets ₹390 Price Target
Kotak Institutional Equities raised its rating on Biocon to Add and set a ₹390 price target, implying around 13% upside from Wednesday’s close. Shares opened 2% higher Thursday.
Kotak Institutional Equities raised its rating on Biocon to Add and set a ₹390 price target, implying around 13% upside from Wednesday’s close. Shares opened 2% higher Thursday.